anmelden
OMX Nordic 40
2.676,26
PKT
-9,30
PKT
-0,35
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu OMX Nordic 40-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 13.04.18 | Novo Nordisk Hold | Jefferies & Company Inc. | |
| 13.04.18 | AstraZeneca buy | Jefferies & Company Inc. | |
| 13.04.18 | ABB (Asea Brown Boveri) overweight | Barclays Capital | |
| 13.04.18 | ABB (Asea Brown Boveri) Conviction Buy List | Goldman Sachs Group Inc. | |
| 13.04.18 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 13.04.18 | Nokia overweight | JP Morgan Chase & Co. | |
| 12.04.18 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 12.04.18 | Nokia buy | UBS AG | |
| 12.04.18 | ABB (Asea Brown Boveri) Conviction Buy List | Goldman Sachs Group Inc. | |
| 12.04.18 | Novo Nordisk buy | Deutsche Bank AG | |
| 12.04.18 | ABB (Asea Brown Boveri) Hold | Société Générale Group S.A. (SG) | |
| 11.04.18 | Novo Nordisk market-perform | Bernstein Research | |
| 11.04.18 | ABB (Asea Brown Boveri) buy | Deutsche Bank AG | |
| 11.04.18 | Nokia buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 09.04.18 | AstraZeneca buy | Deutsche Bank AG | |
| 06.04.18 | ABB (Asea Brown Boveri) Neutral | Citigroup Corp. | |
| 03.04.18 | ABB (Asea Brown Boveri) Conviction Buy List | Goldman Sachs Group Inc. | |
| 28.03.18 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 27.03.18 | Novo Nordisk buy | UBS AG | |
| 19.03.18 | Novo Nordisk market-perform | Bernstein Research | |
| 19.03.18 | AstraZeneca buy | Jefferies & Company Inc. | |
| 15.03.18 | Hennes Mauritz (H M, H&M) Underweight | JP Morgan Chase & Co. | |
| 14.03.18 | AstraZeneca buy | Société Générale Group S.A. (SG) | |
| 12.03.18 | Nokia buy | UBS AG | |
| 12.03.18 | Fortum Sell | Deutsche Bank AG | |
| 09.03.18 | ABB (Asea Brown Boveri) Conviction Buy List | Goldman Sachs Group Inc. | |
| 08.03.18 | Novo Nordisk Underweight | Barclays Capital | |
| 08.03.18 | Nokia Neutral | Goldman Sachs Group Inc. | |
| 05.03.18 | Novo Nordisk Neutral | JP Morgan Chase & Co. | |
| 02.03.18 | Nokia Neutral | Citigroup Corp. | |
| 02.03.18 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 27.02.18 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 26.02.18 | Nokia Neutral | Goldman Sachs Group Inc. | |
| 26.02.18 | ABB (Asea Brown Boveri) Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 26.02.18 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 26.02.18 | Novo Nordisk Hold | Jefferies & Company Inc. | |
| 23.02.18 | Novo Nordisk Neutral | JP Morgan Chase & Co. | |
| 23.02.18 | Novo Nordisk buy | Deutsche Bank AG | |
| 22.02.18 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 21.02.18 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. |
